SPARC promotes cathepsin B-mediated melanoma invasiveness through a collagen i/α2Β1 integrin axis

Journal of Investigative Dermatology

Volumn 131, Issue 12, 2011, Pages 2438-2447

  Girotti, María R ^a,f   Fernández, Marisol ^b   López, Juan A ^c   Camafeita, Emilio ^c   Fernández, Elmer A ^d   Albar, Juan P ^b   Benedetti, Lorena G ^a   Valacco, María P ^a   Brekken, Rolf A ^e   Podhajcer, Osvaldo L ^a   Llera, Andrea S ^a  

^a FUNDACIÓN INSTITUTO LELOIR   (Argentina)

^b CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^c CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^d Intelligent Data Analysis Group   (Argentina)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^f INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN B; COLLAGEN TYPE 1; NERVE CELL ADHESION MOLECULE; OSTEONECTIN; TRANSFORMING GROWTH FACTOR BETA1; UVOMORULIN; VERY LATE ACTIVATION ANTIGEN 2;

ARTICLE; CANCER INVASION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; MELANOMA; MELANOMA CELL; METASTASIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION;

EID: 80855147490     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2011.239     Document Type: Article

References (55)

1. Alonso SR, Tracey L, Ortiz P et al. (2007) A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis. Cancer Res 67:3450-60 (Pubitemid 46724886)
2. Alvarez MJ, Prada F, Salvatierra E et al. (2005) Secreted protein acidic and rich in cysteine produced by human melanoma cells modulates polymorphonuclear leukocyte recruitment and antitumor cytotoxic capacity. Cancer Res 65:5123-32 (Pubitemid 40827321)
3. Assoian RK, Klein EA (2008) Growth control by intracellular tension and extracellular stiffness. Trends Cell Biol 18:347-52
4. Bassuk JA, Pichler R, Rothmier JD et al. (2000) Induction of TGF-beta1 by the matricellular protein SPARC in a rat model of glomerulonephritis. Kidney Int 57:117-28 (Pubitemid 30227759)
5. Bradshaw AD, Sage EH (2001) SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. J Clin Invest 107:1049-54 (Pubitemid 32422898)
6. Bradshaw AD, Puolakkainen P, Dasgupta J et al. (2003) SPARC-null mice display abnormalities in the dermis characterized by decreased collagen fibril diameter and reduced tensile strength. J Invest Dermatol 120:949-55 (Pubitemid 36702902)
7. Brekken RA, Sage EH (2001) SPARC, a matricellular protein: at the crossroads of cell-matrix communication. Matrix Biol 19:816-27
8. Carpenter AE, Jones TR, Lamprecht MR et al. (2006) CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol 7:R100
9. Egeblad M, Rasch MG, Weaver VM (2010) Dynamic interplay between the collagen scaffold and tumor evolution. Curr Opin Cell Biol 22:697-706
10. Fenouille N, Robert G, Tichet M et al. (2011) The p53/p21Cip1/Waf1 pathway mediates the effects of SPARC on melanoma cell cycle progression. Pigment Cell Melanoma Res 24:219-32
11. Francki A, Bradshaw AD, Bassuk JA et al. (1999) SPARC regulates the expression of collagen type I and transforming growth factor-beta1 in mesangial cells. J Biol Chem 274:32145-52
12. Giudici C, Raynal N, Wiedemann H et al. (2008) Mapping of SPARC/BM-40/osteonectin-binding sites on fibrillar collagens. J Biol Chem 283:19551-60
13. Giusti I, D'Ascenzo S, Millimaggi D et al. (2008) Cathepsin B mediates the pH-dependent proinvasive activity of tumor-shed microvesicles. Neo-plasia 10:481-8 (Pubitemid 351657390)
14. Gole B, Duran Alonso MB, Dolenc V et al. (2009) Post-translational regulation of cathepsin B, but not of other cysteine cathepsins, contributes to increased glioblastoma cell invasiveness in vitro. Pathol Oncol Res 15:711-23
15. Golembieski WA, Ge S, Nelson K et al. (1999) Increased SPARC expression promotes U87 glioblastoma invasion in vitro. Int J Dev Neurosci 17:463-72 (Pubitemid 29421833)
16. Keppler D, Waridel P, Abrahamson M et al. (1994) Latency of cathepsin B secreted by human colon carcinoma cells is not linked to secretion of cystatin C and is relieved by neutrophil elastase. Biochim Biophys Acta 1226:117-25 (Pubitemid 24182454)
17. Klose A, Wilbrand-Hennes A, Zigrino P et al. (2006) Contact of high-invasive, but not low-invasive, melanoma cells to native collagen I induces the release of mature cathepsin B. Int J Cancer 118:2735-43 (Pubitemid 43673351)
18. Koblinski JE, Dosescu J, Sameni M et al. (2002) Interaction of human breast fibroblasts with collagen I increases secretion of procathepsin B. J Biol Chem 277:32220-7 (Pubitemid 34969037)
19. Laping NJ, Grygielko E, Mathur A et al. (2002) Inhibition of transforming growth factor (TGF)-beta 1-induced extracellular matrix with a novel inhibitor of the TGF-beta Type I receptor kinase activity: SB-431542. Mol Pharmacol 62:58-64 (Pubitemid 34680516)
20. Ledda F, Bravo AI, Adris S et al. (1997a) The expression of the secreted protein acidic and rich in cysteine (SPARC) is associated with the neoplastic progression of human melanoma. J Invest Dermatol 108:210-4 (Pubitemid 27061034)
21. Ledda MF, Adris S, Bravo AI et al. (1997b) Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells. Nat Med 3:171-6 (Pubitemid 27064701)
22. Lee EO, Kang JL, Chong YH (2005) The amyloid-beta peptide suppresses transforming growth factor-beta1-induced matrix metalloproteinase-2 production via Smad7 expression in human monocytic THP-1 cells. J Biol Chem 280:7845-53
23. Levental KR, Yu H, Kass L et al. (2009) Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 139:891-906
24. Li G, Herlyn M (2000) Dynamics of intercellular communication during melanoma development. Mol Med Today 6:163-9 (Pubitemid 30171367)
25. Lien HC, Hsiao YH, Lin YS et al. (2007) Molecular signatures of metaplastic carcinoma of the breast by large-scale transcriptional profiling: identification of genes potentially related to epithelial-mesenchymal transition. Oncogene 26:7859-71 (Pubitemid 350261788)
26. Linebaugh BE, Sameni M, Day NA et al. (1999) Exocytosis of active cathepsin B enzyme activity at pH 7.0, inhibition and molecular mass. Eur J Biochem 264:100-9 (Pubitemid 29385872)
27. Mack GS, Marshall A (2010) Lost in migration. Nat Biotechnol 28:214-29
28. Massi D, Franchi A, Borgognoni L et al. (1999) Osteonectin expression correlates with clinical outcome in thin cutaneous malignant melanomas. Hum Pathol 30:339-44 (Pubitemid 29125155)
29. Mohamed MM, Sloane BF (2006) Cysteine cathepsins: multifunctional enzymes in cancer. Nat Rev Cancer 6:764-75 (Pubitemid 44450465)
30. Moreno-Bueno G, Peinado H, Molina P et al. (2009) The morphological and molecular features of the epithelial-to-mesenchymal transition. Nat Protoc 4:1591-613
31. Nie J, Chang B, Traktuev DO et al. (2008) IFATS collection: combinatorial peptides identify alpha5beta1 integrin as a receptor for the matricellular protein SPARC on adipose stromal cells. Stem Cells 26:2735-45
32. Podhajcer OL, Benedetti LG, Girotti MR et al. (2008) The role of the matricellular protein SPARC in the dynamic interaction between the tumor and the host. Cancer Metastasis Rev 27:691-705
33. Prada F, Benedetti LG, Bravo AI et al. (2007) SPARC endogenous level, rather than fibroblast-produced SPARC or stroma reorganization induced by SPARC, is responsible for melanoma cell growth. J Invest Dermatol 127:2618-28 (Pubitemid 47585072)
34. Reed MJ, Vernon RB, Abrass IB et al. (1994) TGF-beta 1 induces the expression of type I collagen and SPARC, and enhances contraction of collagen gels, by fibroblasts from young and aged donors. J Cell Physiol 158:169-79
35. Reisenauer A, Eickelberg O, Wille A et al. (2007) Increased carcinogenic potential of myeloid tumor cells induced by aberrant TGF-beta1-signaling and upregulation of cathepsin B. Biol Chem 388:639-50 (Pubitemid 46883451)
36. Robert G, Gaggioli C, Bailet O et al. (2006) SPARC represses E-cadherin and induces mesenchymal transition during melanoma development. Cancer Res 66:7516-23 (Pubitemid 44289206)
37. Roshy S, Sloane BF, Moin K (2003) Pericellular cathepsin B and malignant progression. Cancer Metastasis Rev 22:271-86 (Pubitemid 36561062)
38. Sasaki T, Gohring W, Mann K et al. (1997) Limited cleavage of extracellular matrix protein BM-40 by matrix metalloproteinases increases its affinity for collagens. J Biol Chem 272:9237-43 (Pubitemid 27154933)
39. Schiemann BJ, Neil JR, Schiemann WP (2003) SPARC inhibits epithelial cell proliferation in part through stimulation of the transforming growth factor-beta-signaling system. Mol Biol Cell 14:3977-88 (Pubitemid 37186302)
40. Schultz C, Lemke N, Ge S et al. (2002) Secreted protein acidic and rich in cysteine promotes glioma invasion and delays tumor growth in vivo. Cancer Res 62:6270-7 (Pubitemid 35244481)
41. Shi Q, Bao S, Song L et al. (2007) Targeting SPARC expression decreases glioma cellular survival and invasion associated with reduced activities of FAK and ILK kinases. Oncogene 26:4084-94 (Pubitemid 46920166)
42. Shintani Y, Fukumoto Y, Chaika N et al. (2008) Collagen I-mediated up-regulation of N-cadherin requires cooperative signals from integrins and discoidin domain receptor 1. J Cell Biol 180:1277-89 (Pubitemid 351468480)
43. Smit DJ, Gardiner BB, Sturm RA (2007) Osteonectin downregulates E-cadherin, induces osteopontin and focal adhesion kinase activity stimulating an invasive melanoma phenotype. Int J Cancer 121:2653-60 (Pubitemid 350136408)
44. Sosa MS, Girotti MR, Salvatierra E et al. (2007) Proteomic analysis identified N-cadherin, clusterin, and HSP27 as mediators of SPARC (secreted protein, acidic and rich in cysteines) activity in melanoma cells. Proteomics 7:4123-34 (Pubitemid 350190284)
45. Thiery JP, Acloque H, Huang RY et al. (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139:871-90
46. Thomas PD, Campbell MJ, Kejariwal A et al. (2003a) PANTHER: a library of protein families and subfamilies indexed by function. Genome Res 13:2129-41 (Pubitemid 37161770)
47. Thomas PD, Kejariwal A, Campbell MJ et al. (2003b) PANTHER: a browsable database of gene products organized by biological function, using curated protein family and subfamily classification. Nucleic Acids Res 31:334-41 (Pubitemid 36150398)
48. Thomas SL, Alam R, Lemke N et al. (2010) PTEN augments SPARC suppression of proliferation and inhibits SPARC-induced migration by suppressing SHC-RAF-ERK and AKT signaling. Neuro Oncol 12:941-55
49. Tsao H, Atkins MB, Sober AJ (2004) Management of cutaneous melanoma. N Engl J Med 351:998-1012
50. Turk D, Podobnik M, Popovic T et al. (1995) Crystal structure of cathepsin B inhibited with CA030 at 2.0-A resolution: A basis for the design of specific epoxysuccinyl inhibitors. Biochemistry 34:4791-7
51. Wang H, Fertala A, Ratner BD et al. (2005) Identifying the SPARC binding sites on collagen I and procollagen I by atomic force microscopy. Anal Chem 77:6765-71 (Pubitemid 41547269)
52. Weaver MS, Workman GA, Sage EH (2008) The copper-binding domain of sparc mediates cell survival in vitro via interaction with integrin beta 1 and activation of integrin-linked kinase. J Biol Chem 283:22826-37
53. Wendt MK, Allington TM, Schiemann WP (2009) Mechanisms of the epithelial-mesenchymal transition by TGF-beta. Future Oncol 5:1145-68
54. West BT, Welch KB, Gatecki AT (2007) Linear Mixed Models: A Practical Guide Using Statistical Software. Boca Raton, USA: Chapman & Hall/CRC Press
55. Zhou X, Tan FK, Guo X et al. (2006) Attenuation of collagen production with small interfering RNA of SPARC in cultured fibroblasts from the skin of patients with scleroderma. Arthritis Rheum 54:2626-31 (Pubitemid 44205025)